Blocking VEGF in addition to checkpoint inhibition in RCC

admin

7 years ago

Priti S. Hegde, PhD, Director, CI Franchise Lead, Biomarkers Genentech Roche presents Blocking VEGF in addition to checkpoint inhibition in RCC at the 2016 annual International Kidney Cancer Symposium.